Lignowin 21.3mg Injection
Marketer
Ikon Remedies Pvt Ltd
Salt Composition
Lidocaine (21.3mg)
Overview Lignowin 21.3mg Injection
Novocaine-21.3mg Injection provides localized anesthesia for minor surgical procedures, including dental, oral, diagnostic, and therapeutic interventions. Administered exclusively by medical professionals, this injection temporarily blocks pain signals to the brain, facilitating a comfortable procedure. Generally well-tolerated, it may cause mild, transient injection site reactions like pain, swelling, or redness. Persistent numbness or other side effects warrant immediate medical attention. Prior to administration, patients with cardiac conditions or those on anti-arrhythmic medications should inform their physician. Pregnant or breastfeeding individuals should also consult their doctor before use. Drowsiness may occur; therefore, avoid driving or operating machinery after injection.
Primary Ingredients of Lignowin 21.3mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Lignowin 21.3mg Injection
Targeted regional numbing
Major Benefits of Lignowin 21.3mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Lignowin 21.3mg Injection:
- Injection site reactions (pain, swelling, redness)
How to use Lignowin 21.3mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Lignowin 21.3mg Injection works:
Lignowin 21.3mg Injection provides localized pain relief by interrupting nerve impulses to the brain, thus reducing pain perception.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Lignowin 21.3mg Injection and alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Lignowin 21.3mg is typically deemed safe for use in pregnant individuals. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Lignowin 21.3mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate insignificant danger to the infant.
DrivingSAFE
Administering Lignowin 21.3mg Injection typically does not impair driving ability.
KidneyCAUTION
Administering Lignowin 21.3mg Injection requires careful consideration in individuals with significant renal impairment. Dosage modification of Lignowin 21.3mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Lignowin 21.3mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Lignowin 21.3mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Lignowin 21.3mg Injection :
NA
Facts to Know About Lignowin 21.3mg Injection
| Label | Value |
|---|---|
| Chemical Type | Amide-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavior Class | Amide-based local anesthetics |
3,018 People bought this recently